関連文献

Urinary liver-type fatty acid-binding protein change in gestational diabetes mellitus.

Diabetes Res Clin Pract. 109(3): e36-e38, 2015.PubMed

Urinary Biomarkers and Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Clin J Am Soc Nephrol. 10(11):1956-1963, 2015.PubMed

Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease.

Scand J Clin Lab Invest. 75(5): 421-427, 2015.PubMed

Does elevation of serum creatinine in patients with chronic hepatitis C under therapy of telaprevir mean renal impairment?

Nephrology. 10(4):e0122212, 2015.PubMed

Distinct roles of urinary liver-type Fatty Acid-binding protein in non-diabetic patients with anemia.

PLoS One. 10(5): e0126990, 2015.PubMed

Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy.

PLoS One. 10(4): e0122212, 2015.PubMed

Renoprotective effects of febuxostat in hyperuricemic patients with chronic kidney disease: a parallel-group, randomized, controlled trial.

Clin Exp Nephrol. 19(6): 1044-1053, 2015.PubMed

Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.

Diabetologia. 58(1): 188-198, 2015.PubMed

LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: a retrospective analysis.

Diabetes Res Clin Pract. 106(2): 241-246, 2014.PubMed

NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.

Clin Chem Lab Med. 52(4): 537-546, 2014.PubMed